• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » DTW Podcast: CEO Petrovic explains how Insulet is switching people to `Pods

DTW Podcast: CEO Petrovic explains how Insulet is switching people to `Pods

March 14, 2021 By Tom Salemi

Insulet CEO Shacey Petrovic says she didn’t jump immediately at the chance to join the company.

In an interview with the DeviceTalks Weekly Podcast, Petrovic, who was serving as CEO of a women’s health company when CEO-Patrick Sullivan, her former boss at Cytyc, called her with an offer to serve as Insulet’s chief commercial officer

“I said, `Well, Pat, I’m a CEO now, you know, didn’t you hear?” she joked.

A  chief commercial officer role might be seen as a backward or sideways step from CEO, but Sullivan framed the opportunity differently.

He told Petrovic that he came out of retirement to take the CEO role and didn’t want a long stint as CEO. “He said, `This could be your opportunity to eventually run a public company. If it goes well, I need a successor, the technology is remarkable, and together we can fix this problem.’”

A path to the CEO role at a publicly-traded company was certainly appealing. But Petrovic had more personal reasons for the job.

”My father lives with Type 1 diabetes,” Petrovice says. “I’d really grown up with the disease, and I know about its impact on families and people. So I was immediately taken with the technology and the opportunity. That’s really what convinced me to come over.”

Petrovic took over the CEO role in 2019, and the company is building on the technology that impressed her so much.

In the podcast, Petrovic discussed (links will take you to the exact point in the interview)

  • How the company is engaging the diabetes community.
  • Why it moved away from selling its Omnipod insulin-delivery devices as a durable good.
  • What partnerships with DexCom and Abbott will bring
  • How mobile phones might bolster diabetes management in the future.

We’ll also hear from how our sponsors PSNLabs and PackworldUSA can help you.

We’ll also hear from  Dr. Niki Panich, a practicing physician who is now CEO of a company that can help hospitals and health care facilities process their N95 masks on site. Dr. Panich will be a speaker on this Monday’s DeviceTalks Clubhouse series.

Finally, Chris Newmarker delivers the week’s big Newmarkers Newsmakers involving Baxter, Adaptive Biotechnologies, Boston Scientific, Abbott, and AdvaMed.

Subscribe to the DeviceTalks Weekly Podcast on all your favorite podcast apps.

DeviceTalks by MassDevice · CEO Shacey Petrovic shares how Insulet is convincing people with diabetes to swap shots for `Pods

Filed Under: Device Talks Podcasts, Diabetes, Drug-Device Combinations, Featured, Special Content Tagged With: Abbott, Adaptive Biotechnologies, AdvaMed, Baxter, Boston Scientific, Calumeo, DeviceTalks Weekly, Dexcom, Insulet

More recent news

  • GT Medical raises $53M to support brain tumor treatment
  • Imperative Care, Proximie partner to develop surgical robot to treat stroke
  • Carlsmed launches IPO roadshow
  • Varian introduces IntelliBlate for image-guided cancer therapy in Europe
  • Henry Schein CEO Stanley M. Bergman to retire

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy